Today: 15 May 2026
Why CrowdStrike stock price (CRWD) slid 8% — and what investors watch next week
21 February 2026
2 mins read

Why CrowdStrike stock price (CRWD) slid 8% — and what investors watch next week

New York, February 21, 2026, 10:02 (EST) — The market has closed.

  • CrowdStrike tumbled almost 8% Friday, with cybersecurity stocks under pressure following Anthropic’s rollout of its latest Claude security feature.
  • Cloudflare, Zscaler, Okta, and SailPoint all took hits in the selloff, pushing a cyber ETF down to its lowest finish since November 2023.
  • CrowdStrike is set to report earnings on March 3, with investors watching closely for guidance and any remarks about AI competition.

CrowdStrike Holdings Inc (CRWD) dropped close to 8% Friday, as cybersecurity names sold off after AI startup Anthropic rolled out a security tool for its Claude model. Shares hit $388.60 in the last trade, off 7.9% from Thursday. Volume came in around 8.4 million shares, with prices moving between $431.75 and $387.14.

U.S. markets are closed for the weekend, leaving CrowdStrike investors bracing for what’s next. The stock is staring down a key catalyst: fourth-quarter and full-year earnings, slated to drop after the U.S. close on Tuesday, March 3. A conference call follows that evening.

Selling pressure on Friday hit more than just a single stock. CrowdStrike ranked among the steepest losers. According to Bloomberg, Cloudflare tumbled 8.1%, Zscaler fell 5.5%, SailPoint lost 9.4%, and Okta dropped 9.2%. The Global X Cybersecurity ETF, which tracks a mix of cyber names, closed down 4.9%—its weakest finish since November 2023.

Anthropic has rolled out Claude Code Security, a tool designed to scan software codebases for vulnerabilities and propose fixes, but for now, access is restricted to a select group of enterprise and team clients, CyberScoop reported. According to the company, the tool “reads and reasons about your code the way a human researcher would,” then filters its results through verification steps to reduce false positives. CyberScoop

Anthropic’s Frontier Red Team chief, Logan Graham, pitched the rollout as a practical advantage for security teams stretched thin. “It’s going to be a force multiplier for security teams,” he said to Fortune. Fortune

Now traders are asking if AI tools could actually replace sections of the security software stack instead of just bolting on extra features. Wedbush’s Dan Ives has called the current AI-disruption theme “fighting a ghost”—investors are basically left trying to predict which part of the software landscape is about to get sideswiped. Business Insider

Friday brought sharp losses for software developers—JFrog tumbled 25%, GitLab fell over 8%. Cybersecurity stocks weren’t spared either, with CrowdStrike and Zscaler both in the red. Investors.com flagged the iShares Expanded Tech-Software Sector ETF, now off more than 23% for the year.

Still, the product remains a research preview for now. Anthropic notes it only recommends fixes for humans to check, instead of making automatic updates. That could slow any immediate shakeups. But the bigger question lingers—enterprises might eventually let AI-driven scans take over from some dedicated tools.

This week, CrowdStrike’s setup depends on whether buyers return following Friday’s drop—and what the company has to say about demand, pricing, and competition in its upcoming report. Investors are also primed to hear how management positions AI, watching closely for any commentary on whether it’s fueling security budgets or squeezing margins and renewals.

All eyes turn to Monday’s open, with traders waiting to see if Friday’s jolt was just a blip or the start of something bigger. But the real event circled on calendars is March 3, set for the earnings report and whatever signals come out of that call.

Stock Market Today

  • Putnam High Income Securities Fund (PCF) Ex-Dividend Date and Dividend Details
    May 15, 2026, 10:57 AM EDT. Putnam High Income Securities Fund (PCF) will trade ex-dividend on May 19, 2026, with a monthly dividend of $0.058, payable May 29, 2026. The dividend represents approximately 1.03% of the recent $5.63 stock price, implying shares may drop by this amount on the ex-dividend date. PCF's 12-month performance ranges from $5.36 to $6.51, with a recent price near $5.64. The fund's annualized yield is estimated at 12.36%, based on its latest dividend. Shares were down about 0.9% in recent trading.

Latest articles

Plug Power Stock Drops Again: The $5 Billion Hydrogen Turnaround Faces Its Cash Test

Plug Power Stock Drops Again: The $5 Billion Hydrogen Turnaround Faces Its Cash Test

15 May 2026
Plug Power shares fell 1.7% to $3.725 in early Nasdaq trading Friday, following a volatile week after first-quarter results. The company reported a 22% revenue increase to $163.5 million and improved gross margin, but its net loss widened to $245.3 million and operating cash use rose to $150 million. Plug ended March with $802 million in cash and expects $142 million from a hydrogen asset sale in June.
Why Ford Motor Company Stock Is Sliding After Its AI Data Center Rally

Why Ford Motor Company Stock Is Sliding After Its AI Data Center Rally

15 May 2026
Ford shares dropped 7% to $13.43 in early Friday trading, reversing part of a rally sparked by the launch of its new Ford Energy unit. The subsidiary, announced this week, will sell large battery energy storage systems to utilities and data centers, with first deliveries expected in late 2027. CEO Jim Farley said Ford is in the contracting phase with several customers. The stock had surged 13% Wednesday after Morgan Stanley highlighted the business.
Biogen Closes Apellis Deal; APLS Leaves Nasdaq As $5.6 Billion Rare-Disease Bet Begins

Biogen Closes Apellis Deal; APLS Leaves Nasdaq As $5.6 Billion Rare-Disease Bet Begins

15 May 2026
Biogen has closed its acquisition of Apellis Pharmaceuticals, making Apellis a wholly owned subsidiary and delisting its shares from Nasdaq. Apellis shareholders receive $41 per share in cash plus a contingent value right tied to Syfovre sales. Biogen gains the drugs Empaveli and Syfovre, and expands into kidney disease. Biogen borrowed $2 billion to help finance the deal.
Nokia Oyj Stock Pulls Back After AI Rally: What Investors Need to Know

Nokia Oyj Stock Pulls Back After AI Rally: What Investors Need to Know

15 May 2026
Nokia’s U.S.-listed shares dropped about 5% Friday, trading at $13.74 after a recent AI-driven surge. The decline followed a rally sparked by Cisco’s report of $5.3 billion in AI infrastructure orders from hyperscalers. Nokia saw a 54% jump in first-quarter operating profit and named Siemens’ Emma Falck as president of Mobile Infrastructure, effective September 1.
Anglo American JSE share price: De Beers writedown puts Teck deal and dividend dates in the spotlight
Previous Story

Anglo American JSE share price: De Beers writedown puts Teck deal and dividend dates in the spotlight

Alphabet GOOG stock jumps 3.7% — what to watch next week for Google shares
Next Story

Alphabet GOOG stock jumps 3.7% — what to watch next week for Google shares

Go toTop